Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT05537025 · COMPLETED
Trial details
- NCT number
- NCT05537025
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-09-05
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.